Comparative Study
N-trifluoroacetyladriamycin-14-valerate: additional mouse antitumor and toxicity studies
- PMID: 272230
Item in Clipboard
Comparative Study
N-trifluoroacetyladriamycin-14-valerate: additional mouse antitumor and toxicity studies
Cancer Treat Rep.
1978 Jan.
No abstract available
Similar articles
-
Antitumor activity of N-trifuloroacetyladriamycin-14-valerate.Cancer Treat Rep. 1978 Jan;62(1):105-10. Cancer Treat Rep. 1978. PMID: 626988
-
N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin.Cancer Res. 1975 May;35(5):1365-8. Cancer Res. 1975. PMID: 1054622
-
Comparative antineoplastic activity of adriamycin and N-trifluoroacetyladriamycin-14-valerate.Cancer Treat Rep. 1978 Jan;62(1):111-7. Cancer Treat Rep. 1978. PMID: 626989
-
Protein-associated DNA breaks and DNA-protein cross-links caused by DNA nonbinding derivatives of adriamycin in L1210 cells.Cancer Res. 1981 Mar;41(3):1006-10. Cancer Res. 1981. PMID: 7459847
-
[New anthracyclines and multidrug resistance].Haematologica. 1991 Jun;76 Suppl 3:181-3. Haematologica. 1991. PMID: 1752512 Review. Italian. No abstract available.
Cited by
-
Distribution of radioactivity and anthracycline-fluorescence in tissues of mice one hour after [14C]-labeled AD 32 administration. Evidence for tissue aglycone formation.Cancer Chemother Pharmacol. 1981;6(1):25-30. doi: 10.1007/BF00253006. Cancer Chemother Pharmacol. 1981. PMID: 6944160
-
Pharmacologic studies with radiolabeled N-trifluoroacetyladriamycin-14-valerate (AD 32). Comparison of total anthracycline fluorescence and radioactivity in mouse serum and urine.Cancer Chemother Pharmacol. 1980;4(2):79-82. doi: 10.1007/BF00254026. Cancer Chemother Pharmacol. 1980. PMID: 7389059
-
Comparative effects of adriamycin and DNA-non-binding analogues on DNA, RNA, and protein synthesis in vitro.Cancer Chemother Pharmacol. 1987;20(4):277-84. doi: 10.1007/BF00262577. Cancer Chemother Pharmacol. 1987. PMID: 2446792
-
Pharmacologic rationale for intravesical N-trifluoroacetyladriamycin-14-valerate (AD 32): a preclinical study.Cancer Chemother Pharmacol. 1991;28(1):1-6. doi: 10.1007/BF00684948. Cancer Chemother Pharmacol. 1991. PMID: 2040028
-
Cancer chemotherapy: new developments and changing concepts.Drugs. 1980 Nov;20(5):375-97. doi: 10.2165/00003495-198020050-00003. Drugs. 1980. PMID: 7002528 Review. No abstract available.